1,015
Views
37
CrossRef citations to date
0
Altmetric
Review Article

Reviewing the use of ethylcellulose, methylcellulose and hypromellose in microencapsulation. Part 1: materials used to formulate microcapsules

&
Pages 129-157 | Received 06 Oct 2010, Accepted 19 May 2011, Published online: 14 Sep 2011

References

  • Shaw A. (1994). Report: Guideline for submitting supporting documentation in drug applications for the manufacture of drug substances. Food and Drug Administration: Center for Drug Evaluation and Research, Department of Health and Human Services.
  • Green BK, Schleicher L. (1956). Manifold record material. US 2730456.
  • Green BK, Schleicher L. (1957). Microscopic capsules containing oil. US 2800457.
  • Anonymous. (1962). Printing process. DE 1128872.
  • Berman E. (1965). Method of making transfer prints. US 3219446.
  • Miller RE, Anderson JL. (1964). Minute polymeric capsules for drugs. US 3155590.
  • CIPRO® prescribing information. (2007). http://www.univgraph.com/bayer/inserts/ciprotab.pdf.
  • Pöllinger N, Michaelis J, Benke K, Rupp R, Bücheler M. (1997). Flavor-masked pharmaceutical compositions. US 5695784.
  • Pöllinger N, Michaelis J, Benke K, Rupp R, Bücheler M. (2000). Flavor-masked pharmaceutical compositions. US 6136347.
  • RxList: The Internet Drug Index website. (2007). http://www.rxlist.com/cgi/generic/kclsr.htm.
  • Lippmann I, Popli SD, Miller LG, Bell LG. (1981). Controlled release potassium dosage form. US 4259315 A.
  • Hsiao C, Chou C-TK. (1989). Controlled release potassium chloride. US 4863743 A.
  • Chemtob C. (1984). Microencapsulation by coacervation. Labo-Pharma—Problemes et Techniques, 346:702–709.
  • Chemtob C. (1987). Microencapsulation with ethyl cellulose. The role and effects of so-called “coacervation protecting and inducing” agents. STP Pharma, 3:418–424.
  • Samejima M. (1985). Microencapsulated drugs. Kagaku to Kogyo (Osaka, Japan), 59:452–457.
  • Benita S. (2006). Microencapsulation: Methods and industrial applications. Boca Raton, FL, USA: CRC Press, Taylor & Francis Group.
  • Ghosh SK. (2006). Functional coatings: By polymer microencapsulation. Weinheim, Berlin: Wiley-VCH.
  • Whateley TL. (1992). Microencapsulation of drugs. Chur, Switzerland: CRC Press, Harwood Academic Publishers.
  • Vandegaer JE. (1974). Microencapsulation. Berlin, Germany: Springer.
  • Lim F. (1984). Biomedical applications of microencapsulation. Boca Raton, FL, USA: CRC Press.
  • Dimari S, Funke W, Haralson MA, Hunkeler D, Joos-Miller B, Matsumoto A, Okay O, Otsu T, Powers AC, Prokop A, Wang TG, Whitesell RR. (1998). Microencapsulation/microgels/iniferters. Berlin, Germany: Springer-Verlag Telos.
  • Deasy PB. (1984). Microencapsulation and related drug processes. New York, NY, USA; Oxford, UK: Marcel Dekker, Inc.
  • Thies C. (2001). Microencapsulation of food ingredients. Leatherhead, Surrey, England: Leatherhead Food Research Association.
  • Cohen S, Bernstein H. (1996). Microparticulate systems for the delivery of proteins and vaccines. New York, NY, USA: Marcel Dekker, Inc.
  • Cheu SJ, Chen RR, Chen PF, Lin WJ. (2001). In vitro modified release of acyclovir from ethyl cellulose microspheres. J Microencapsul, 18:559–565.
  • Zhang X, Lin T, Li X, Mei D, Li D, Gao H. (2000). Studies on microcapsules of norfloxacin. Shenyang Yaoke Daxue Xuebao, 17:247–249.
  • Zhang ZY, Ping QN, Xiao B. (2000). Microencapsulation and characterization of tramadol-resin complexes. J Control Release, 66:107–113.
  • Chan LW, Heng PW. (1998). Effects of poly(vinylpyrrolidone) and ethylcellulose on alginate microspheres prepared by emulsification. J Microencapsul, 15:409–420.
  • Arabi H, Hashemi SA, Fooladi M. (1996). Microencapsulation of allopurinol by solvent evaporation and controlled release investigation of drugs. J Microencapsul, 13:527–535.
  • Singh J, Robinson DH. (1990). Controlled release captopril microcapsules: Effect of ethyl cellulose viscosity grade on the in vitro dissolution from microcapsules and tableted microcapsules. J Microencapsul, 7:67–76.
  • Dragan D, Airinei A, Carpov A. (1985). Dissolution studies of microencapsulated 4-sulphonamidophenoxyacetic acid: Effect of preparative variables on dissolution. J Microencapsul, 2:223–234.
  • Goto S, Uchida T, Aoyama T. (1985). Preparation and biopharmaceutical evaluation of microcapsules of ampicillin. J Pharmacobio-Dyn, 8:270–277.
  • Lee HJ, Lee MH, Shim CK. (1984). Preparation and evaluation of ethyl cellulose microcapsules of indomethacin. Arch Pharm Res, 7:33–40.
  • Deasy PB, Brophy MR, Ecanow B, Joy MM. (1980). Effect of ethylcellulose grade and sealant treatments on the production and in vitro release of microencapsulated sodium salicylate. J Pharm Pharmacol, 32:15–20.
  • Assimopoulou AN, Papageorgiou VP. (2004). Preparation and release studies of alkannin-containing microcapsules. J Microencapsul, 21:161–173.
  • ETHOCEL™ website. (2007). www.ethocel.com.
  • Gantt M, Venkatesh GM, Vishnupad KS. (2000). Controlled release potassium chloride tablet formulations. WO 2001043725 A1.
  • Venkatesh G, Kramer C. (2003). Controlled release potassium chloride tablets. US 20050013860 A1.
  • Uddin MS, Hawlader MN, Zhu HJ. (2001). Microencapsulation of ascorbic acid: Effect of process variables on product characteristics. J Microencapsul, 18:199–209.
  • Koida Y, Hirata G, Samejima M. (1983). Studies on microcapsules. II. Influence of molecular weight of ethylcellulose in the microencapsulation of ascorbic acid. Chem Pharm Bull, 31:4476–4482.
  • Guyot M, Fawaz F. (1998). Nifedipine loaded-polymeric microspheres: Preparation and physical characteristics. Int J Pharm, 175:61–74.
  • Chen H, Wu J-C, Chang C-L. (1994). Preparation and release behavior of cellulose triacetate-ethylcellulose microcapsules containing theophylline by using emulsion nonsolvent addition method. Huaxue, 52:301–310.
  • Wu JC, Jean WJ, Chen H. (1994). Evaluation of the properties of ethylcellulose-cellulose triacetate microcapsules containing theophylline prepared by different microencapsulation techniques. J Microencapsul, 11:507–518.
  • Uchida T, Yasutake T, Goto S. (1992). Utility of mixture of commercially available polymers as constituents of sustained-release microcapsules containing cefadroxil or theophylline. Chem Pharm Bull, 40:463–466.
  • Tsujiyama T, Suzuki N, Kuriki T, Kawata M, Goto S. (1990). Pharmacological evaluation of hydroxypropylcellulose-ethylcellulose microcapsules containing piretanide. J Pharmacobio-Dyn, 13:1–9.
  • Tsujiyama T, Suzuki N, Kawata M, Uchida T, Goto S. (1989). Preparation and pharmacokinetic and pharmacodynamic evaluation of hydroxy propyl cellulose-ethyl cellulose microcapsules containing piretanide. J Pharmacobio-Dyn, 12:311–323.
  • Samejima M, Hirata G, Ishibashi T. (1985). Process for preparing free-flowing ethyl cellulose microcapsules. US 4542042.
  • Samejima M, Hirata G, Koida Y, Kobayashi Y, Kida A. (1985). Enteric microcapsules. EP 77956 B1.
  • Sarin JPS, Khanna NM, Gupta SK, Khanna M, Singh S. (1985). Subdermal drug implants. GB 2103927 B2.
  • Beatty ML. (1982). Powdered microencapsulated bacampicillin acid addition salt and oral suspensions containing it. US 4321253 A.
  • Meier PM, Sparks RE, Lindan O. (1974). Report: Adsorption control and kinetic model for microencapsulated carbon. Case West. Reserve Univ., Cleveland, OH, USA: U.S. Nat. Tech. Inform. Serv., PB Rep. (1972).
  • Morris NJ, Warburton B. (1982). Three-ply walled w/o/w microcapsules formed by a multiple emulsion technique. J Pharm Pharmacol, 34:475–479.
  • Singla AK, Nagrath A. (1988). Stability of ascorbic acid-zinc sulfate tablets. Drug Dev Ind Pharm, 14:1471–1479.
  • Chalabala M. (1984). Microencapsulation of a water-soluble substance. Pharmazie, 39:643–644.
  • Tsai YH, Huang LC. (1985). [Studies on the microencapsulation of indomethacin by a phase separation technique]. Gaoxiong Yi Xue Ke Xue Za Zhi, 1:551–561.
  • Vitkova M, Chalabala M, Rak J, Pikulikova Z. (1983). Study of drug microforms. IV. Preparation of microcapsules containing potassium chloride. Farm Obz, 52:531–538.
  • Baichwal MR, Abraham IA. (1980). Microencapsulation of metronidazole. Indian J Pharm Sci, 42:48–51.
  • Baichwal MR, Chidambharam PP. (1977). Ascorbic acid protection by embedding. Indian J Pharm Sci, 39:129–132.
  • Morse LD. (1971). Microencapsulation form of antiinflammatory indomethacin. US 3557279 A.
  • Barik BB, Sahoo SK, Chatterjee S, Dinda A. (2004). Effect of a protective colloid in microencapsulation using ethylcellulose and Eudragit RS 100. J Teach Res Chem, 11:53–57.
  • Becourt P, Boltri L, Cioloca N, Bruschi SDL, Mapelli LG, Rabaglia L, Schwabe D. (2002). Taste masked oral composition of telithromycin. WO 2004009059 A1.
  • Bruschi SDL, Mapelli LG, Rabaglia L, Boltri L. (2002). Process for the preparation of pharmaceutical microcapsules with enhanced taste-masking and high dissolution rate. WO 2004009058 A1.
  • Becourt P, Chauvin J, Schwabe D. (2002). Pharmaceutical formulation having a masked taste comprising at a cellulose polymer and a methacrylic polymer. WO 2003000225 A3.
  • Becourt P, Cioloca N, Boltri L, Bruschi SDL, Mapelli LG, Rabaglia L, Schwabe D. (2002). Taste masked oral composition of telithromycin. US 2004013737 A1.
  • Barzola G, Piacentini D, Wexler P. (2001). Microencapsulation of secnidazole by fluid-bed coating: Relation between taste masking and coating membrane thickness. Revista SAFYBI, 40:21–27.
  • Elbary AA, El Razaz MA, El-Khateeb MM, Mohamed AI. (2001). Formulation and evaluation of controlled release ibuprofen granules and coprecipitates. Bull Fac Pharm, 39:83–102.
  • Rhee GJ, Do KC, Kim EH, Park JB, Whang SJ. (1997). Development of multiparticulate-system composed of sustained-release microspheres of pseudoephedrine hydrochloride and immediate-release pellets of terfenadine using solvent evaporation method and spherically agglomerated crystallization process. Yakhak Hoechi, 41:305–311.
  • Kostova I, Valova N, Parusheva K, Georgiev G. (1994). Precipitation of enteric copolymers from their acetone solutions and their applications for microencapsulation of ampicillin trihydrate. Godishnik na Sofiiskiya Universitet “Sv. Kliment Okhridski”. Khimicheski Fakultet, 81:69–80.
  • Georgiev G, Valova N, Tarkalanov N, Parusheva K, Kostova I. (1994). Regulation of the microencapsulated ampicillin trihydrate released from calcium alginate gel matrix. Godishnik na Sofiiskiya Universitet “Sv. Kliment Okhridski”. Khimicheski Fakultet, 81:107–116.
  • Bodmeier R, Chen H. (1990). Indomethacin polymeric nanosuspensions prepared by microfluidization. J Control Release, 12:223–233.
  • Safwat SM, El-Shanawany S. (1989). Evaluation of sustained-release suppositories containing microencapsulated theophylline and oxyphenbutazone. J Control Release, 9:65–73.
  • Ichikawa H, Fukumori Y. (2000). A novel positively thermosensitive controlled-release microcapsule with membrane of nano-sized poly(N-isopropylacrylamide) gel dispersed in ethylcellulose matrix. J Control Release, 63:107–119.
  • Sfar S, Karoui M. (1989). Microencapsulation of potassium chloride by spray drying, and study of the release before and after treatment of the microcapsules by fats. Conference proceedings: Congr. Int. Technol. Pharm., Association de Pharmacie Galénique Industrielle.
  • Snipes WC, Wagner SJ. (1989). Controlled release potassium chloride composition. US 4832955.
  • Shin SC, Koh IB. (1989). Effect of polyisobutylene and sealant treatments on ethyl cellulose-walled methyldopa microcapsules. Yakche Hakhoechi, 19:29–37.
  • Chikamatsu Y, Ando Y, Hasebe K, Hayashi K. (1984). Microencapsulation of tryptophan. JP 01040011 B4.
  • Khanna NM, Gupta SK, Sarin JS, Singh S, Kanna M. (1982). Sustained-release pharmaceutical pellets for subcutaneous implantation. DE 3228533 A1.
  • Masayoshi T S and Goichi H. (1981). Preparation of microcapsules. JP 58049433 A2.
  • Kato T. (1981). Sustained-release pharmaceutical microcapsules. JP 58035110 A2.
  • Samejima M, Hirata G, Koida Y. (1983). Process for preparing pharmaceutically active compound-containing microcapsules. US 4389331.
  • Kassem AA, Badawy AA, El-Sayed AA, El-Mahrouk GM. (1978). Preparation of non-pareil seeds of thiamine hydrochloride. Pharm Ind, 40:396–399.
  • Sriwongjanya M, Bodmeier R. (1997). Entrapment of drug-loaded ion-exchange particles within polymeric microparticles. Int J Pharm, 158:29–38.
  • Moldenhauer MG, Nairn JG. (1994). Solubility parameter effects on microencapsulation in the presence of polyisobutylene. J Control Release, 31:151–162.
  • Moldenhauer MG, Nairn JG. (1992). The control of ethylcellulose microencapsulation using solubility parameters. J Control Release, 22:205–218.
  • Moldenhauer MG, Nairn JG. (1991). The effect of rate of evaporation on the coat structure of ethylcellulose microcapsules. J Control Release, 17:49–60.
  • Moldenhauer MG, Nairn JG. (1990). Formulation parameters affecting the preparation and properties of microencapsulated ion-exchange resins containing theophylline. J Pharm Sci, 79:659–666.
  • Motycka S, Newth CJ, Nairn JG. (1985). Preparation and evaluation of microencapsulated and coated ion-exchange resin beads containing theophylline. J Pharm Sci, 74:643–646.
  • Goto S, Moriya F, Kawata M, Kimura T. (1984). Preparation and biopharmaceutical evaluation of microcapsules of amoxicillin. J Microencapsul, 1:137–155.
  • Motycka S, Nairn JG. (1979). Preparation and evaluation of microencapsulated ion-exchange resin beads. J Pharm Sci, 68:211–215.
  • Yokota Y, Ishibashi K, Yamada K, Tanaka S, Pondevida JL, Dominguez LG, Lalusis BM, Pigao CG, Panlasigui RA. (1994). Preparation and performance of slow release microcapsules containing nutrient by complex emulsion method. Philipp J Sci, 123:121–133.
  • Ishibashi K, Yamada K, Noda Y, Shigashide F. (1985). Preparation of medicinal carbon and microcapsules containing acetylsalicylic acid on medicinal carbon. Pharm Ind, 47:1185–1189.
  • Ishibashi K, Yamada K, Noda Y, Higashide F. (1984). Medicinal carbon from industrial active carbon. 4. Preparation of microcapsules containing aspirin adsorbed on medicinal carbon. Yakuzaigaku, 44:66–71.
  • Ishibashi K, Yamada K, Noda Y, Nozawa Y, Miyagishima A, Higashide F. (1984). Medicinal carbon from industrial active carbon. 3. Preparation and properties of microcapsules containing medicinal carbon. Yakuzaigaku, 44:57–65.
  • Calanchi M, Gentilini L. (1985). Sustained release formulation of water-soluble components. EP 0177000 A1.
  • Golzi R, Boltri L, Stollberg C. (2004). Microcapsules by coacervation containing a pharmaceutical incorporated in the coating polymer. WO 2004105725 A3.
  • Murthy TEGK, Chowdary KPR. (2004). Influence of polymer solvent on permeability and release of diclofenac from ethylcellulose films and microcapsules. Int J Pharm Excipients, 3:39–45.
  • Giannini RP, Bashour DA. (1989). Amoxicillin microencapsulated granules. WO 9001932 A1.
  • Ayer AD, Yieh RLC, Pollack BJ, Wong PSL. (1994). Valproate for sustained antiepileptic therapy. WO 9427587 A3.
  • Wan LS, Heng PW, Chia CG. (1992). Plasticizers and their effects on microencapsulation process by spray-drying in an aqueous system. J Microencapsul, 9:53–62.
  • Hasçiçek C, Gönül N, Erk N. (2003). Mucoadhesive microspheres containing gentamicin sulfate for nasal administration: Preparation and in vitro characterization. Farmaco, 58:11–16.
  • Donbrow M, Benita S. (1977). The effect of polyisobutylene on the coacervation of ethyl cellulose and the formation of microcapsules [proceedings]. J Pharm Pharmacol, 29 Suppl:4P.
  • Kawashima Y, Lin SY, Kasai A, Takenaka H, Matsunami K, Nochida Y, Hirose H. (1984). Drug release properties of the microcapsules of adriamycin hydrochloride with ethyl cellulose prepared by a phase separation technique. Drug Dev Ind Pharm, 10:467–479.
  • Koida Y, Kobayashi M, Hirata G, Samejima M. (1984). Studies on microcapsules. III. Influence of molecular weight of polyisobutylene in the microencapsulation of ascorbic acid. Chem Pharm Bull, 32:4971–4978.
  • Lin SY, Yang JC, Jiang SS. (1985). Studies on microencapsulation. (I). Micromeritic properties of theophylline microcapsules prepared by coacervation-phase separation method. Taiwan Yaoxue Zazhi, 37:1–10.
  • Nixon JR, Agyilirah GA. (1982). The effect of polyisobutylene on the properties of ethyl cellulose-walled microcapsules of phenobarbitone sodium. Acta Pharm Technol, 28:137–140.
  • Samejima M, Hirata G, Koida Y. (1982). Studies on microcapsules. I. Role and effect of coacervation-inducing agents in the microencapsulation of ascorbic acid by a phase separation method. Chem Pharm Bull, 30:2894–2899.
  • Powell TC, Anderson JL. (1971). Polymer-coated small particles. US 3576759.
  • Al-Omran MF, Al-Suwayeh SA, El-Helw AM, Saleh SI. (2002). Taste masking of diclofenac sodium using microencapsulation. J Microencapsul, 19:45–52.
  • Lippold BH, Sutter BK, Lippold BC. (1989). Parameters controlling drug release from pellets coated with aqueous ethyl cellulose dispersion. Int J Pharm, 54:15–25.
  • Chowdary KPR, Nageswara Rao G. (1985). Studies on a new technique of microencapsulation: Part II. Indian Drugs, 23:58.
  • Fekete PI. (1992). The effect of surfactants on the properties of microcapsules. Drug Target Deliv, 1:55–63.
  • Fekete P, Bezzegh D, Zukovics K, Jámbor Z, Tombor J. (1989). Process for preparing microcapsules comprising ethyl cellulose. GB 2226804 B2.
  • Singh J, Robinson DH. (1988). Controlled release captopril microcapsules: Effect of non-ionic surfactants on release from ethyl cellulose microcapsules. J Microencapsul, 5:129–137.
  • Abu-Izza KA, Garcia-Contreras L, Lu DR. (1996). Preparation and evaluation of sustained release AZT-loaded microspheres: Optimization of the release characteristics using response surface methodology. J Pharm Sci, 85:144–149.
  • Chemtob C, Gruber T, Chaumeil JC. (1989). Influence of polyisobutylene on microencapsulation of metronidazole. Drug Dev Ind Pharm, 15:1161–1174.
  • Adikwu MU. (1995). Release behavior from latex-treated, matrix tablet formulations. Pharmakeutike, 8:83–88.
  • Ahlert G, Evert S. (1995). Medicated dental floss containing oxygen generating agent. US 5423337 A.
  • Bergisadi N, Gurvardar D. (1989). Studies on piroxicam microcapsules and in vitro release kinetics. Acta Pharm Turcica, 31:161–165.
  • Chen H, Wu JC, Chen HY. (1995). Preparation of ethylcellulose microcapsules containing theophylline by using emulsion non-solvent addition method. J Microencapsul, 12:137–147.
  • Al-Omran MF, Al-Suwayeh SA, El-Helw AM, Saleh SI. (2002). Formulation and physicochemical evaluation of diclofenac sodium chewable tablets. Saudi Pharm J, 10:177–183.
  • Bettman MJ, Percel PJ, Powell TC. (1997). Effervescent microcapsules. US 5639475.
  • Al-Omran MF, Al-Suwayeh SA, El-Helw AM, Saleh SI. (2002). Taste masking of diclofenac sodium employing four different techniques. Saudi Pharm J, 10:106–113.
  • Bhalerao SS, Lalla JK, Rane MS. (2001). Study of processing parameters influencing the properties of diltiazem hydrochloride microspheres. J Microencapsul, 18:299–307.
  • Biju SS, Saisivam S, Rajan NS, Mishra PR. (2004). Dual coated erodible microcapsules for modified release of diclofenac sodium. Eur J Pharm Biopharm, 58:61–67.
  • Chow AHL, Ho SSS, Tong HHY, Ma HHM. (1998). Parameters affecting in-liquid drying microencapsulation and release rate of cefaclor. Int J Pharm, 172:113–125.
  • Alam AS, Eichel HJ. (1982). Sustained release pharmaceutical formulation. US 4316884 A.
  • Bodmeier R, Chen H. (1989). Preparation and characterization of microspheres containing the anti-inflammatory agents, indomethacin, ibuprofen, and ketoprofen. J Control Release, 10:167–175.
  • Chowdary KPR, Rao GN. (1984). Studies of a new technique of microencapsulation by ethyl cellulose. Indian J Pharm Sci, 46:213–215.
  • Alam AS, Eichel HJ. (1980). Indoprofen—a continuous release pharmaceutical. DE 3001797 A1.
  • Alpar OH. (1981). Sustained-release characteristics of tablets of ethylcellulose microcapsules containing potassium phenethicillin. Farmaco Prat, 36:366–373.
  • Bodmeier R, Wang J. (1993). Microencapsulation of drugs with aqueous colloidal polymer dispersions. J Pharm Sci, 82:191–194.
  • Chowdary KPR, Rao GN. (1985). Studies on a new technique of microencapsulation. Part III: Effect of certain variables on size distribution of the microcapsules. Indian Drugs, 22:381–382.
  • Alpar HO, Walters V. (1981). The prolongation of the in vitro dissolution of a soluble drug (phenethicillin potassium) by microencapsulation with ethyl cellulose. J Pharm Pharmacol, 33:419–422.
  • Bodmeier R, Wang H, Dixon DJ, Mawson S, Johnston KP. (1995). Polymeric microspheres prepared by spraying into compressed carbon dioxide. Pharm Res, 12:1211–1217.
  • Chowdary KPR, Rao GN. (1985). Studies on a new technique of microencapsulation. Part V: Microencapsulation of aspirin by ethyl cellulose. Indian Drugs, 22:479–481.
  • Aly AM, Saleh SI, Ahmed SM, Abdel-Rahaman SI, Aboutaleb AE. (1993). Microencapsulation of nitrofurantoin by coacervation using certain polymeric materials. Bull Pharm Sci, 16:73–87.
  • Chowdary KPR, Murty ASR. (1985). Controlled nitrofurantoin release through microencapsulation. Indian J Pharm Sci, 47:161–62.
  • Amperiadou A, Georgarakis M. (1995). Controlled release salbutamol sulfate microcapsules prepared by emulsion solvent-evaporation technique and study on the release affected parameters. Int J Pharm, 115:1–8.
  • Chowdary KPR, Rao GN. (1986). Studies on a new technique of microencapsulation. Part VI: Microencapsulation of indomethacin. Indian Drugs, 23:508–509.
  • Anderson JL. (1971). Report: Microencapsulated cloud seeding materials. Capsular Res. Prod. Dev. Dep., Natl. Cash Register Co., Dayton, OH, USA: U.S. Clearinghouse Fed. Sci. Tech. Inform.
  • Cameroni R, Coppi G, Forni F, Iannuccelli V, Bernabei MT. (1985). [Sulfadiazine: Release from microcapsules]. Boll Chim Farm, 124:393–400.
  • Chowdary KPR, Babu KVVS. (1988). A comparative evaluation of ethyl cellulose, gelatin and calcium alginate microcapsules prepared by complex emulsion methods. Indian J Pharm Sci, 50:173–175.
  • Anderson JL, Haines RC Jr, Powell TC. (1972). Minute capsules and their manufacture en masse. US 3694372 A.
  • Carpov A, Oita N, Tolea A, Pavelescu M. (1982). Antiinflammatory and antirheumatic composition containing acetylsalicylic acid and aminocaproic acid. RO 78211 B.
  • Chowdhary KPR, Ramesh KVRNS. (1993). Studies on microencapsulation of diltiazem. Indian J Pharm Sci, 55:52–54.
  • Andre-Abrant A, Taverdet J-L, Jay J. (2001). Microencapsulation by solvent evaporation. Eur Polym J, 37:955–963.
  • Carpov A, Oita N, Tolea A. (1980). Microencapsulation of calcium rutin and magnesium rutin. RO 74767 B.
  • Chowdary KPR, Ratna JV. (1993). A comparative evaluation of ethylcellulose, methylcellulose, and cellulose acetate microcapsules prepared by a complex emulsion method. Indian Drugs, 30:179–184.
  • Cedrati N, Bonneaux F, Labrude P, Maincent P. (1997). Structure and stability of human hemoglobin microparticles prepared with a double emulsion technique. Artif Cells Blood Substit Immobil Biotechnol, 25:457–462.
  • Chowdary KPR, Sastry VH. (1997). Microencapsulation of diclofenac. A comparison of drug release from various microcapsules. Eastern Pharmacist, 40:119–122.
  • Chukwu A, Agarwal SP, Adikwu MU. (1991). Some properties of chloroquine phosphate and quinine hydrochloride microcapsules. STP Pharma Sci, 1:117–120.
  • Cohen EC. (1986). Microencapsulated astringent hemostatic agents and their use. US 4597960 A.
  • Charle R, Zviak C, Kalopissis G. (1973). Cosmetic composition containing nail polish solvents enclosed in microcapsules. FR 2033292 B3.
  • Cordes G. (1972). Microencapsulation of pharmaceuticals. DE 2223896 A1.
  • Barik BB, Gupta BK, Pal M. (1993). Preparation and evaluation of rifampicin microcapsules. Eastern Pharmacist, 36:173–175.
  • Chattaraj SC, Das SK. (1990). Effect of formulation variables on the preparation and in vitro—in vivo evaluation of cimetidine release from ethyl cellulose micropellets. Drug Dev Ind Pharm, 16:283–293.
  • Cowsar DR, Lewis DH, Whitehead GW. (1978). Report: Study of reactive materials for development of new protective clothing concepts. South. Res. Inst., Birmingham, AL, USA: Gov. Rep. Announce. Index (U.S.).
  • Cowsar DR. (1980). Fabric containing microcapsules of chemical decontaminants encapsulated within semipermeable polymers. US 4201822 A.
  • Cristallini C, Enriquez De Grassi G, Guardines L, Gaussmann R. (1984). A controlled-release anti-inflammatory drug. Studies on microcapsules. Appl Biochem Biotechnol, 10:267–272.
  • Chemtob C, Chaumeil JC, N’Dongo M. (1986). Microencapsulation by ethyl cellulose phase separation: Microcapsule characteristics. Int J Pharm, 29:1–7.
  • Curea E, Ban I, Leucuta ES, Bojita M, Cardan E. (1987). Effect of buffering and microencapsulation of acetylsalicylic acid on dissolution rate and bioavailability. Farmacia (Bucharest, Romania), 35:75–82.
  • Chemtob C, Chaumeil JC, N’Dongo M. (1986). Tablets of metronidazole microcapsules: Release characteristics. Int J Pharm, 29:83–92.
  • D’Onofrio GP, Oppenheim RC, Bateman NE. (1979). Encapsulated microcapsules. Int J Pharm, 2:91–99.
  • Anon. (1974). Stabilization of vitamins and minerals by microencapsulation. NL 7215117 A.
  • Morishita M, Ohno M, Sumita Y, Soejima R. (1985). Formulation design of rokitamycin (TMS-19-Q) tablet and its evaluation. Conference proceedings: Recent Adv. Chemother., Proc. Int. Congr. Chemother., 14th, University Tokyo Press.
  • Morre DM, Morre DJ, Cooper R, Chang MN. (2002). Tea catechins in sustained release formulations as cancer specific proliferation inhibitors. US 6410052 B1.
  • Murav’ev IA, Andreeva IN. (1987). The effect of microencapsulation on release rate of euphylline from tablets. Farmatsiya (Moscow, Russian Federation), 36:19–21.
  • Nikolaev AS, Vinogradova LF, Kamenskaya MV. (1990). Biopharmaceutical examinations of dosage forms of microencapsulated acetylsalicylic acid. Farmatsiya (Moscow, Russian Federation), 39:20–24.
  • Nikolayev AS, Gebre-Mariam T. (1993). Preparation and bioavailability studies of aspirin ethylcellulose microcapsules. Indian Drugs, 30:392–397.
  • Özyazici M, Sevgi F, Ertan G. (1996). Micromeritic studies on nicardipine hydrochloride microcapsules. Int J Pharm, 138:25–35.
  • Raghubanshi RS, Jayaswal SB, Singh J. (1991). Controlled-release tablets of ethyl cellulose coated salbutamol sulphate microcapsules. Pharmazie, 46:144–145.
  • Sajeev C, Vinay G, Archna R, Saha RN. (2002). Oral controlled release formulation of diclofenac sodium by microencapsulation with ethyl cellulose. J Microencapsul, 19:753–760.
  • Sevgi F, Ozyazici M, Güneri T. (1994). Sustained-release dosage form of phenylpropanolamine hydrochloride. Part II: Formulation and in vitro release kinetics from tableted microcapsules. J Microencapsul, 11:335–344.
  • Dahlström H, Eriksson S. (1971). The effect of microencapsulation with ethyl cellulose upon the disintegration in vivo and the dissolution of iron tablets. Acta Pharm Suec, 8:505–508.
  • Shopova S, Tomova V, Radeva K, Ateva P, Tyutyulkova N, Gorancheva Y. (1987). Controlled release of acetylsalicylic acid from Aspropharm tablets. Farmatsiya (Sofia, Bulgaria), 37:22–27.
  • Farid DJ, Blourchian N, Nokhodchi. (1994). Study of agents affecting the physical properties of aspirin-tableted microcapsules. J Sch Pharm Med Sci Univ Tehran, 4:27–39.
  • Tirkkonen S, Paronen P. (1993). Release of indomethacin from tabletted ethylcellulose microcapsules. Int J Pharm, 92:55–62.
  • He F, Hou H. (1989). Preparation of vitamin C microcapsule. Zhongguo Yiyao Gongye Zazhi, 20:462–464.
  • Tuncel T, Bergsadi N, Akin L, Otük G, Kusçu I. (1996). In vitro and in vivo studies on microcapsules and tabletted microcapsules of cephradine. Pharmazie, 51:168–171.
  • Hosny EA, Al-Helw AA-RM, Niazy EM. (1998). In-vitro and in-vivo evaluation of commercial and microencapsulated sustained-release tablets containing diclofenac sodium. Saudi Pharm J, 6:65–70.
  • Vitkova M, Chalabala M, Rak J, Pikulikova Z. (1986). Studies of drug microforms. XIII187. Tablets with potassium chloride from ethyl cellulose microcapsules. Cesk Farm, 35:171–175.
  • Jalsenjak I, Nixon JR, Senjkovic R, Stivic I. (1980). Sustained-release dosage forms of microencapsulated isoniazid. J Pharm Pharmacol, 32:678–680.
  • Yazan Y, Demirel M, Güler E. (1995). Preparation and in vitro dissolution of salbutamol sulphate microcapsules and tabletted microcapsules. J Microencapsul, 12:601–607.
  • Kassem AA, Badawy AA, El-Sayed AA. (1975). Microencapsulation of L-ascorbic acid. Bull Fac Pharm, 12:11–24.
  • Zia H, Falamarzian M, Raisi A, Montaseri H, Needham TE. (1991). Biopharmaceutical evaluation of a tablet dosage form made from ethyl cellulose encapsulated aspirin particles. J Microencapsul, 8:21–28.
  • Kondo A, Miyano S, Kitajima M, Arai F. (1972). Encapsulated aspirin tablets. JP 49062623 A2.
  • Lin S-Y, Yang JC. (1986). Studies on microencapsulation. Part IV. Effect of ethylene-vinyl acetate as a coacervation-inducing agent on the production and release behavior of chlorpromazine hydrochloride microcapsules and tabletted microcapsules. J Control Release, 3:221–228.
  • Vitkova M, Chalabala M, Rak J, Prochazka R. (1994). Ethylcellulose to prepare a matrix system of a hydrophilic drug by the microencapsulation process. STP Pharma Sci, 4:486–491.
  • Kaltsatos V, Rollet M, Perez J. (1989). Optimization of a method of microencapsulation by phase separation. Role of the hydroxypropyl methyl cellulose as a nucleating agent. STP Pharma, 5:96–102.
  • Lin SY, Chen FJ. (1992). Cooling rate affecting the formation and properties of theophylline ethylcellulose microcapsules prepared by phase separation method. Pharm Acta Helv, 67:91–96.
  • Whitaker DM Sr. (1991). Stabilized perfume-containing microcapsules and method of preparing the same. US 5051305 A.
  • Wieland-Berghausen S, Schote U, Frey M, Schmidt F. (2002). Comparison of microencapsulation techniques for the water-soluble drugs nitenpyram and clomipramine HCl. J Control Release, 85:35–43.
  • Morse LD, Hammes PA. (1974). Microencapsulated multivitamin compositions. GB 1371840 A.
  • Morse LD, Walker WG, Hammes PA. (1978). Microencapsulation. US 4123382 A.
  • Nasa SL, Yadav S. (1989). Microencapsulation of metoprolol tartrate using phase separation coacervation techniques. Eastern Pharmacist, 32:133–134.
  • Anon. (1967). Manufacture of small capsules by coating with cellulose ethers or other polymers. NL 6611661.
  • Nixon JR, Wong KT. (1990). Evaluation of drug permeation through polymeric membranes as a model for release. (II). Ethyl cellulose-walled microcapsules. Int J Pharm, 58:31–40.
  • Powell TC. (1993). Controlled-release calcium channel blocker microcapsules. US 5252337 A.
  • Doshi HA, Nafde P, Shrivastava R. (1994). A study of microencapsulation by coacervation phase separation of ethylcellulose. Indian J Pharm Sci, 56:195–197.
  • Rak J, Vitkova M, Chalabala M, Heliova M. (1984). Study on drug microforms. X. Manufacture and in vitro evaluation of ethyl cellulose microcapsules with sulfamethoxydiazine. Farm Obz, 53:445–454.
  • El-Helw AER. (1987). Effect of microcapsule size on release and bioavailability of phenazopyridine hydrochloride from ethyl cellulose walled microcapsules. Acta Pharm Technol, 33:145–148.
  • Fan G, Qu R, Zhou W, Yan Y, Zhao Q. (1996). Research on microencapsulation of water-soluble vitamins. Tianjin Daxue Xuebao, 29:592–597.
  • Friend DR, Ng S, Sarabia RE, Weber TP, Geoffroy J-M. (1997). Taste-masked microcapsule compositions and methods of manufacture. WO 9814179 A1.
  • Inoe N. (1992). Microencapsulated anti-AIDS virus agents. JP 06316524 A2.
  • John PM. (1979). Controlled-release composition. US 4153677 A.
  • Sveinsson SJ, Kristmundsdottir T. (1992). Naproxen microcapsules: Preparation and in vitro characterization. Int J Pharm, 82:129–133.
  • Szretter D, Zakrzewski Z. (1984). Microencapsulation of riboflavin by dispersion-congealing technique or by simple coacervation. Farm Pol, 40:275–279.
  • Koida Y, Kobayashi M, Samejima M. (1986). Studies on microcapsules. IV. Influence of properties of drugs on microencapsulation and dissolution behavior. Chem Pharm Bull, 34:3354–3361.
  • Kristl A, Bogataj M, Mrhar A, Kozjek F. (1991). Preparation and evaluation of ethyl cellulose microcapsules with bacampicillin. Drug Dev Ind Pharm, 17:1109–1130.
  • Lin SY. (1985). Influence of coacervation-inducing agents and cooling rates on the preparation and in vitro release of bleomycin hydrochloride microcapsules. J Microencapsul, 2:91–101.
  • Vitkova M, Chalabala M, Rak J, Heliova M. (1984). Drug microforms. VII. Microcapsules of chloramphenicol. Farm Obz, 53:241–250.
  • Morishita M, Inaba Y, Fukushima M, Hattori Y, Kobari S, Matsuda T. (1981). Microcapsule preparation. JP 56019324 B4.
  • Mortada SM. (1982). Preparation of ethyl cellulose microcapsules using the complex emulsion method. Pharmazie, 37:427–429.
  • Murthy TEGK, Chowdary KPR. (2005). Formulation and evaluation of ethylcellulose-coated diclofenac sodium microcapsules: Influence of solvents. Indian J Pharm Sci, 67:216–219.
  • Pérez-Martínez JI, Morillo E, Maqueda C, Ginés JM. (2001). Ethyl cellulose polymer microspheres for controlled release of norfluazon. Pest Manag Sci, 57:688–694.
  • Ravichandran V, Sivanand V, Raghuraman S, Velrajan G, Mohan SBN, Subash S, Bennitojohnson D, Sankar V. (2001). Microencapsulation of nimesulide for sustained release. Eastern Pharmacist, 44:111–114.
  • Das SK. (1991). In vitro dissolution profile of theophylline loaded ethylcellulose microspheres prepared by emulsification solvent evaporation. Drug Dev Ind Pharm, 17:2521–2528.
  • Ruiz R, Sakr A, Sprockel OL. (1990). A study on the manufacture and in vitro dissolution of terbutaline sulfate microcapsules and their tablets. Drug Dev Ind Pharm, 16:1829–1842.
  • Elbahri Z, Taverdet JL. (2005). Optimization of an herbicide release from ethylcellulose microspheres. Polym Bull, 54:353–363.
  • Sheorey DS, Sai MS, Dorle AK. (1991). A new technique for the encapsulation of water insoluble drugs using ethyl cellulose. J Microencapsul, 8:359–368.
  • Uno K, Ohara Y, Arakawa M, Kondo T. (1984). A new method of preparing monocored water-loaded microcapsules using interfacial polymer deposition process. J Microencapsul, 1:3–8.
  • Huang HP, Ghebre-Sellassie I. (1989). Preparation of microspheres of water-soluble pharmaceuticals. J Microencapsul, 6:219–225.
  • Jones DS, Pearce KJ. (1995). An investigation of the effects of some process variables on the microencapsulation of propranolol hydrochloride by the solvent evaporation method. Int J Pharm, 118:199–205.
  • Yang CY, Tsay SY, Tsiang RC. (2000). An enhanced process for encapsulating aspirin in ethyl cellulose microcapsules by solvent evaporation in an O/W emulsion. J Microencapsul, 17:269–277.
  • Kentepozidou A, Kiparissides C. (1995). Production of water-containing polymer microcapsules by the complex emulsion/solvent evaporation technique. Effect of process variables on the microcapsule size distribution. J Microencapsul, 12:627–638.
  • Yang CY, Tsay SY, Tsiang RC. (2001). Encapsulating aspirin into a surfactant-free ethyl cellulose microsphere using non-toxic solvents by emulsion solvent-evaporation technique. J Microencapsul, 18:223–236.
  • Kiritani M. (1973). Particle encapsulation. JP 50094112 A2.
  • Yang C-Y, Tsay S-Y, Chen B-K. (2001). Application of gelatin for encapsulating aspirin into ethylcellulose microcapsule in an O/W emulsion. Chem Eng Commun, 186:241–255.
  • Lin WJ, Wu TL. (1999). Modification of the initial release of a highly water-soluble drug from ethyl cellulose microspheres. J Microencapsul, 16:639–646.
  • Yang F, Chu Y, Huo L, Yang Y, Liu Y. (2005). Fabrication of polyaniline/ethylcellulose composite microspheres by microencapsulation. Chem Lett, 34:388–389.
  • Morishita M, Inaba Y, Fukushima M. (1973). Microencapsulation of hydrogenated macrolide antibiotics. JP 49100216 A2.
  • Zandi M, Pourjavadi A, Hashemi SA, Arabi H. (1998). Preparation of ethylcellulose microcapsules containing perphenazine and polymeric perphenazine based on acryloyl chloride for physical and chemical studies of drug release control. Polym Int, 47:413–418.
  • Morishita M, Inaba Y, Fukushima M, Hattori Y, Kobari S, Matsuda T. (1976). Encapsulation of medicaments. US 3960757 A.
  • Manekar NC, Puranik PK, Joshi SB. (1992). Microencapsulation of terbutaline sulphate by the solvent evaporation technique. J Microencapsul, 9:481–487.
  • Manekar NC, Puranik PK, Joshi SB. (1993). Microencapsulation of propranolol hydrochloride by the solvent evaporation technique. Eastern Pharmacist, 36:119–122.
  • Dubernet C, Rouland JC, Benoit JP. (1991). Ibuprofen-loaded ethylcellulose microspheres: Analysis of the matrix structure by thermal analysis. J Pharm Sci, 80:1029–1033.
  • Ghorab MM, Zia H, Luzzi LA. (1990). Preparation of controlled release anticancer agents. I: 5-Fluorouracil-ethyl cellulose microspheres. J Microencapsul, 7:447–454.
  • Ibrahim SA, Sayed HA, Hafez E, El-Sayed AM, Ali SS. (1990). Preparation and evaluation of sustained release ethyl cellulose encapsulated aspirin. Bull Pharm Sci, 13:235–46.
  • Khalil SAH, El-Gamal SS. (1973). Coating of pharmaceuticals by phase separation of cellulose derivatives. Preparation and in vitro release. Pharmazie, 28:385–388.
  • Uchida T, Fujimoto I, Goto S, Aoyama T. (1987). Preparation and evaluation of ethyl cellulose microcapsule containing cefadroxil or cephradine. Yakuzaigaku, 47:254–259.
  • Kosenko NV, Lebedenko VYa, Makharadze RV. (1986). Microencapsulation of ethmozin and microcapsule properties. Farmatsiya (Moscow, Russian Federation), 35:23–26.
  • Kristmundsdottir T, Ingvarsdottir K. (1994). Ibuprofen microcapsules: The effect of production variables on microcapsule properties. Drug Dev Ind Pharm, 20:769–778.
  • Ku YS, Kang HH. (1991). Microencapsulation of propranolol hydrochloride with ethylcellulose by solvent evaporation method in liquid paraffin. Nonchong - Han’guk Saenghwal Kwahak Yonguwon, 48:109–128.
  • Yoshida NH. (1972). Preparation of minuscule capsules. US 3657144.
  • Manekar NC, Puranik PK, Joshi SB. (1992). Microencapsulation of propranolol hydrochloride by the solvent evaporation technique. j Microencapsul, 9:63–66.
  • Zhu R, Xue F, Yang L, Zhao D. (1992). Microencapsulation of vitamin C by the solvent vaporation process. Gongneng Gaofenzi Xuebao, 5:175–180.
  • Zulkarnain AK. (1996). The effect of cellulose derivatives on lynestrenol release rate from microencapsulated dosage form and in vitro-in vivo correlation. Majalah Farmasi Indonesia, 7:180–190.
  • Fukumori Y, Ichikawa H, Yamaoka Y, Akaho E, Takeuchi Y, Fukuda T, Kanamori R, Osako Y. (1991). Microgranulation and encapsulation of pulverized pharmaceutical powders with ethyl cellulose by the Wurster process. Chem Pharm Bull, 39:1806–1812.
  • Fukumori Y, Ichikawa H, Yamaoka Y, Akaho E, Takeuchi Y, Fukuda T, Kanamori R, Osako Y. (1991). Effect of additives on physical properties of fine ethyl cellulose microcapsules prepared by the Wurster process. Chem Pharm Bull, 39:164–169.
  • Han M, Li K. (2001). Method for preparing microencapsulated multiple yeast enzyme composite for skin care. CN 1401314 A.
  • Kim YJ, Yun CS, Seong KS. (1999). Preparation of microencapsulated ferrous sulfate. KR 211285 B1.
  • Knezevic Z, Gosak D, Hraste M, Jalsenjak I. (1998). Fluid-bed microencapsulation of ascorbic acid. J Microencapsul, 15:237–252.
  • Persson NO, Lindblom G, Bogentoft C, Appelgren C. (1981). NMR diffusion measurement in polymeric membranes used for controlled drug release. Acta Pharm Suec, 18:35–44.
  • Senjkovic R, Jalsenjak I. (1984). Influence of the atomization time on the properties of ethylcellulose microcapsules of isoniazid prepared by a fluidized bed. J Microencapsul, 1:241–247.
  • Nixon JR, Meleka MR. (1984). The preparation and characterization of ethylcellulose-walled theophylline microcapsules. J Microencapsul, 1:53–64.
  • Nixon JR, Nimmannit U. (1985). Cellulose-walled microcapsules: 1. The effect of the solvent-non solvent proportions on the preparation of microcapsules from the system ethyl cellulose-chloroform-ethane diol. J Microencapsul, 2:103–110.
  • El-Helw A-RM Bayomi, MA. (2000). Effect of core modification on the release of chlorpheniramine maleate from ethylcellulose and cellulose acetate propionate microcapsules. Saudi Pharm J, 8:31–38.
  • Salib NN, El-menshaway ME, Ismail AA. (1976). Ethyl cellulose as a potential sustained release coating for oral pharmaceuticals. Pharmazie, 31:721–723.
  • Itoh M, Nakano M, Juni K, Sekikawa H. (1980). Sustained release of sulfamethizole, 5-fluorouracil, and doxorubicin from ethylcellulose-polylactic acid microcapsules. Chem Pharm Bull, 28:1051–1055.
  • Wu JC, Jean WJ, Chen H. (1993). Preparation and release behavior of ethylcellulose microcapsules containing theophylline dispersed in cellulose triacetate matrixes. J Chin Chem Soc, 40:23–28.
  • Yazici E, Oner L, Kas HS, Hincal AA. (1996). Phenytoin sodium microcapsules: Bench scale formulation, process characterization and release kinetics. Pharm Dev Technol, 1:175–183.
  • Forni F, Coppi G, Vandelli MA, Cameroni R. (1991). Drug release from spray-dried and spray-embedded microparticles of diltiazem hydrochloride. Chem Pharm Bull, 39:2091–2095.
  • Du J, Ding X, Lin X, Zheng C, Zhang W, Peng Y. (2001). Microencapsulated powders containing vitamins and polymers for sustained-release. CN 1380056 A.
  • Lin Y, Zhu D, Ding F, Zan J, Jiang G. (2004). Reverse temperature sensitive in-situ formation type implanting agent for injection. CN 1631357 A.
  • Anon. (1981). Double-layered microcapsules. JP 58035111 A2.
  • Kitakoji T, Yoneda Y, Murakawa K. (1973). Double-wall microencapsulation for pressure-sensitive copying paper. JP 49121786 A2.
  • Liao C-W, Lin P, Weng C-N. (2003). An oral controlled-release formulation comprising ethylcellulose enteric encapsulant. US 2004208928 A1.
  • Mao L, Zhang R-H. (1994). Physicochemical properties and their influencing factors of microencapsulation of sulfadiazine with spray dry process. Zhongguo Yiyao Gongye Zazhi, 25:114–117.
  • Vo XM, Nguyen TL, Nguyen TMN. (2000). Pilot assay of the metronidazole microcapsules by separating the lyophilization phase from heating spray. Tap Chi Duoc Hoc, 11:15–17.
  • Yamada N, Nakamura H, Abe E. (1996). Preparation by spray drying of microcapsules with a core of a water soluble substance and a shell of ethylcellulose. Funtai Kogaku Kaishi, 33:632–637.
  • Rak J, Vitkova M, Chalabala M, Szechenyi S, Heinrich J. (1984). Study on drug microforms. XI. Biopharmaceutical evaluation of ethyl cellulose microcapsules with sulfamethoxydiazine. Farm Obz, 53:515–521.
  • Hu Z, Kimura G, Ito Y, Mawatari S, Shimokawa T, Yoshikawa H et al. (1999). Technology to obtain sustained release characteristics of drugs after delivered to the colon. J Drug Target, 6:439–448.
  • Rani KNS, Goundalkar AG, Prakasam K. (1994). Preparation and evaluation of microspheres of diclofenac sodium. Indian J Pharm Sci, 56:45–50.
  • Karakasa I, Yagi N, Shibata M, Kenmotsu H, Sekikawa H, Takada M. (1994). Sustained release of phenytoin following the oral administration of phenytoin sodium/ethylcellulose microcapsules in human subjects and rabbits. Biol Pharm Bull, 17:432–436.
  • Kato T. (1981). Enhancement of antitumor effects by magnetic control of microencapsulated anticancer drug. Gan To Kagaku Ryoho, 8:698–706.
  • Shindo M. (1988). Microencapsulated anticancer drug. Experimental studies on microencapsulation of peplomycin and application to arterial microchemoembolization. Akita Igaku, 15:531–541.
  • Kato T, Nemoto R. (1978). Microencapsulation of mitomycin C for intraarterial infusion chemotherapy. Proc Jpn Acad Ser B Phys Biol Sci, 54:413–417.
  • Kato T, Nemoto R, Mori H, Unno K, Goto A, Harada M, Homma M. (1979). Preparation and characterization of ferromagnetic mitomycin C microcapsules as a means of the magnetic control of anticancer drugs. Proc Jpn Acad Ser B Phys Biol Sci, 55:470–475.
  • Tanaka N. (1978). Photodecomposable microcapsules. JP 54109078 A2.
  • Kimura G, Hu Z, Mawatari S, Shimokawa T, Takada K. (1999). Technology to obtain sustained-release characteristics of drugs after delivery to the colon. Drug Deliv Syst, 14:191–196.
  • Dailey OD Jr, Dowler CC. (1995). Polymeric microcapsules of selected herbicides: Preparation and efficacy. Trends Org Chem, 5:83–102.
  • Kozlova IV, Dontsova GI, Chlenov VA, Lebedenko VIa, Griadunova GP. (1977). [Microencapsulation process for water-soluble vitamins]. Farmatsiia, 26:37–39.
  • Uchida T, Goto S. (1988). Biopharmaceutical evaluation of sustained-release ethylcellulose microcapsules containing cefadroxil and cephradine using beagle dogs. Chem Pharm Bull, 36:2135–2144.
  • Deshpande AV, Njikam AP. (1977). Microencapsulation of paracetamol. Indian J Pharm Sci, 39:76–78.
  • Lavasanifar A, Ghalandari R, Ataei Z, Zolfaghari ME, Mortazavi SA. (1997). Microencapsulation of theophylline using ethylcellulose: In vitro drug release and kinetic modelling. J Microencapsul, 14:91–100.
  • Uchida T, Fujimoto I, Goto S. (1989). Biopharmaceutical evaluation of sustained-release ethylcellulose microcapsules containing amoxicillin using beagle dogs. Chem Pharm Bull, 37:3416–3419.
  • Ducroux P, Aiache S, Renoux R, Aiache JM. (1984). Study on the bioavailability of acetylsalicylic acid gelatin capsules. Conference proceedings: Biopharm. Pharmacokinet., Eur. Congr., 2nd, Lavoisier.
  • Utsuki T, Brem H, Pitha J, Loftsson T, Kristmundsdottir T, Tyler BM, Olivi A. (1996). Potentiation of anticancer effects of microencapsulated carboplatin by hydroxypropyl-α-cyclodextrin. J Control Release, 40:251–260.
  • Echigo M, Murota H, Goto A, Unno K, Kato T, Nemoto R, Mori H, Homma M. (1982). Microencapsulation of neoplasm inhibitors. 2. Preparation and characteristic of the ferromagnetic microcapsules. Byoin Yakugaku, 8:242–245.
  • Lin SY, Ho LT, Chiou HL. (1988). Insulin controlled-release microcapsules to prolong the hypoglycemic effect in diabetic rats. Biomater Artif Cells Artif Organs, 16:815–828.
  • Fernandez-Urrusuno R, Gines JM, Morillo E. (2000). Development of controlled release formulations of alachlor in ethylcellulose. J Microencapsul, 17:331–342.
  • Maysinger D, Jalsenjak I. (1983). In situ absorption and in vitro release of microencapsulated cimetidine. Int J Pharm, 17:129–134.
  • Yalabik-Kas HS. (1983). Microencapsulation of 1,4-benzodiazepin-2-one derivatives. Oxazepam. DOGA Bilim Dergisi, Seri C: Tip, 7:75–84.
  • Gold O. (2001). Prolonged-release microgranules for 4-nitro-2-phenoxymethanesulfonanilide. EP 1269998 A1.
  • Goto S. (1994). Pharmacokinetic considerations related to the bioavailability of sustained-release microencapsulated drugs for oral use. Conference proceedings: 9th International Symposium on Microencapsulation, Ed. de Sante, Paris.
  • Okamoto Y, Konno A, Togawa K, Kato T, Tamakawa Y, Amano Y. (1986). Arterial chemoembolization with cisplatin microcapsules. Br J Cancer, 53:369–375.
  • Goto S, Tsuruta M, Sato H, Nakayama T. (1973). Evaluation of microcapsules. I. Yakuzaigaku, 33:95–100.
  • Guo J, Xu H. (1998). Preparation and pharmacokinetics of sustained-release isoniazid. Zhongguo Yaoxue Zazhi, 33:95–98.
  • Portnyagina VA, Fedorova IP, Pochinok TV, Tarahovskii ML, Zadorozhnaya TD, Yatsenko KV. (1991). Microcapsules of sodium 2,3-dimercaptopropane sulfonate (unithiol). Farmatsiya (Moscow, Russian Federation), 40:24–27.
  • Putcha L, McDonough J, Boland EJ, Dixon H, Persyn JT, Vasisht N. (2005). Controlled release compositions and methods for using same. WO 2003105811 A8.
  • Murgu L, Oita M, Dogaru I. (1981). New pharmaceutical forms of aspirin. Experimental pharmacodynamic study. Farmacia (Bucharest, Romania), 29:229–238.
  • Nemoto R, Kato T. (1981). Experimental intra-arterial infusion of Microencapsulated Mitomycin C into pelvic organs. Br J Urol, 53:225–227.
  • Nemoto R, Kato T. (1984). Microencapsulation of anticancer drug for intraarterial infusion, and its clinical application. Conference proceedings: Microspheres Drug Ther.: Pharm., Immunol., Med. Aspects, Elsevier.
  • Palomo ME, Ballesteros MP, Frutos P. (1996). Solvent and plasticizer influences on ethylcellulose-microcapsules. J Microencapsul, 13:307–318.
  • Dailey OD Jr, Dowler CC. (1996). Herbicidal evaluation of polymeric microcapsules of cyanazine. Part II. Conference proceedings: 212th ACS National Meeting, American Chemical Society.
  • Eley JG, Whateley TL, Goldberg JA, Kerr DJ, McArdle CS, Anderson J, Kato T. (1992). Microencapsulation of mitomycin C using ethylcellulose and its evaluation in patients with liver metastases. Drug Target Deliv, 1:293–303.
  • Takada K. (2000). Nonoral micro- or milli-capsules having three-layer structure, and manufacture thereof. WO 2001089486 A1.
  • Jouffroy C. (1984). Rodenticide formulation containing scilliroside. FR 2496403 B1.
  • Wang Y, Bai G, Sun W, Zhang H. (1993). Extraction of chromium (VI) by trioctylamine microcapsule. Yingyong Huaxue, 10:53–55.
  • Kato T, Unno K, Goto A. (1985). Ethylcellulose microcapsules for selective drug delivery. Meth Enzymol, 112:139–150.
  • Wang Y, Bai G, Xie P, Zhang H. (1993). Method on microencapsulation of α -1,4-glucan-4-glucanohydrolase. Mo Kexue Yu Jishu, 13:40–45.
  • Wang YJ, Liu CB, Bai GY, Chu Y, Wu ZS, Chang HZ. (1995). Immobilization of catalase with ethylcellulose microcapsule. Shengwu Huaxue Zazhi, 11:201–204.
  • Wang YJ, Liu CB, Bai GY, Chu Y, Wang FP, Ma ZF, Zhang HZ. (1996). Microcapsule-immobilized catalase. Gaodeng Xuexiao Huaxue Xuebao, 17:953–956.
  • Matsumoto K, Ugajin Y. (1989). Microencapsulation of pharmaceuticals with magnetic substances, and preparation of enzyme-bound magnetic microcapsules. JP 02229545 A2.
  • Zhang X, Zou L, Qi H, Liu D. (1993). Studies of the preparation of sodium ampicillin-ethylcellulose microcapsules and the bioavailability in rabbits. Shandong Yike Daxue Xuebao, 31:71–73.
  • Morse LD, Hammes PA. (1972). Comestible fat product containing nutrition-enriching iron encapsulated to prevent rancidness. FR 2107697.
  • Sakuma S, Atsumi K. (1990). Anticariogenic dentifrices containing microencapsulated hydroxylapatite and microencapsulated fluoride. DE 3821256 A1.
  • Harte KM. (1978). Folic acid animal feed materials. US 4087556 A.
  • Heintz T, Teipel U. (2000). Coating of particulate energetic materials. Conference proceedings: International Annual Conference of Fraunhofer-Institut fur Chemische Technologie, Fraunhofer-Institut fur Chemische Technologie.
  • Szretter D, Zakrzewski Z. (1987). Technology of ascorbic acid microencapsulation. Acta Pol Pharm, 44:352–356.
  • Kallstrand AGV, Mattsson KJ, Sjoqvist RI. (1986). Controlled release oral mixtures containing microencapsulated pharmaceuticals. GB 2122490 B2.
  • Kantor ML, Steiner SS, Pack HM. (1989). Microencapsulation of fish oil. EP 336662 A3.
  • Yokoyama T, Shibata K. (1987). Microencapsulated alkaline earth sulfide phosphors. JP 63178194 A2.
  • Katsumi M. (1983). Method for fabrication of microencapsulated toners. JP 60120367 A2.
  • Pöllinger N, Michaelis J, Benke K, Rupp R, Bücheler M. (1999). Microencapsulated taste-masked pharmaceutical compositions. EP 551820 B1.
  • Hirata G, Niki Y. (1975). Microencapsulation of water-soluble medicines. JP 50030136 B4.
  • Dobetti L, Cogliati M, Calanchi M. (1999). Microencapsulation by coacervation. The influence of paraffin (coacervation-inducing agent) on drug release. Boll Chim Farm, 138:55–56.
  • Das SK. (1993). Effect of polybutadiene on the encapsulation efficiency of ethyl cellulose microcapsules of sulphadiazine. J Microencapsul, 10:437–447.
  • Kondo A, Ueda T. (1973). Microencapsulation. JP 49125516 A2.
  • Morse LD, Hammes PA. (1974). Microencapsulated product. ZA 7207752 A.
  • Nakajima T, Takashima Y, Iida K, Mitsuta H, Koishi M. (1987). Preparation and in vitro evaluation of sustained-release suppositories containing microencapsulated indomethacin. Chem Pharm Bull, 35:1201–1206.
  • Takashima Y, Nakajima T, Aikawa K, Iida K, Koishi M. (1985). Microencapsulation of drugs with ethyl cellulose for controlled-release. JP 62132820 A2.
  • Anon. (1981). Rapid-release microcapsules containing ethyl cellulose and carbonates. JP 01005004 B4.
  • Kato T, Nemoto R. (1978). Preparation and properties of microencapsulated mitomycin C. IRCS Med Sci, 6:311.
  • Hecquet B, Fournier C, Depadt G, Cappelaere P. (1984). Preparation and release kinetics of microencapsulated cisplatin with ethylcellulose. J Pharm Pharmacol, 36:803–807.
  • Farivar M, Kas HS, Oner L, Hincal AA. (1993). Factorial design-based optimization of the formulation of isosorbide-5-mononitrate microcapsules. J Microencapsul, 10:309–317.
  • Heintz T, Krober H, Teipel U. (2001). Microencapsulation of reactive materials. Schuettgut, 7:27–32.
  • Hitchcock CJ. (1980). Delayed release of sodium fluoride. US 4220552 A.
  • Dévay A, Rácz I. (1984). [Production of microcapsules containing tofizopam]. Acta Pharm Hung, 54:84–89.
  • Dévay A, Rácz I. (1987). [Preparation of acetylsalicylic acid microcapsules. II. Study of operational parameters]. Acta Pharm Hung, 57:261–265.
  • Gentilini L. (1986). Deodorant containing tannic acid microcapsules with modulating effect on perspiration. EP 201134 A3.
  • Dubernet C, Benoit JP, Peppas NA, Puisieux F. (1990). Ibuprofen-loaded ethylcellulose microspheres: Release studies and analysis of the matrix structure through the Higuchi model. J Microencapsul, 7:555–565.
  • Dyug EM, Gladkikh SP, Prokopishin VI, Lebedenko VYa, Demina NB. (1982). Study of the microencapsulation process for novocainamide. Farmatsevtichnii Zhurnal (Kiev), 2:62–65.
  • Jani GK, Chauhan GM, Gohel M, Patel J. (1992). Microencapsulation of indomethacin by complex emulsification. Indian Drugs, 29:450–452.
  • Goto S, Nakashima J, Tsuruta M, Sato H, Nakayama T. (1976). Evaluation of microcapsules. Part III. Determination of dissolution rate, coating thickness and external form of microencapsulated aspirins, and effect of microencapsulation with ethylcellulose on excretion pattern of salicylates. Yakuzaigaku, 36:1–6.
  • el-Helw AM, Nixon JR. (1987). Specific surface area measurement of ethyl cellulose-walled microcapsules containing theophylline. J Microencapsul, 4:111–119.
  • El-Helw A, El-Said Y, Ramadan E. (1988). Effect of core modification on the release and bioavailability of phenazopyridine hydrochloride from ethyl cellulose-walled microcapsules. Acta Pharm Fennica, 97:29–35.
  • Kaeser-Liard B, Kissel T, Sucker H. (1984). Manufacture of controlled release formulations by a new microencapsulation process, the emulsion-induction techniques. Acta Pharm Technol, 30:294–301.
  • Hasan M, Najib N, Suleiman M, El-Sayed Y, Abdel-Hamid M. (1992). In vitro and in vivo evaluation of sustained-release and enteric-coated microcapsules of diclofenac sodium. Drug Dev Ind Pharm, 18:1981–1988.
  • Kimura T. (1971). Dampening process for offset printing. DE 2113452 A.
  • Mallick S, Gupta BK, Ghosal SK. (1999). Formulation and evaluation of microencapsulation of verapamil hydrochloride coated with ethylcellulose, Eudragit RS and Eudragit RL. Acta Pol Pharm, 56:289–295.
  • Kitajima M, Miyano S, Kondo A. (1969). Enzyme-containing microcapsules. Kogyo Kagaku Zasshi, 72:493–499.
  • Mallick S, Roy K, Chakraborty A, Saha S. (2002). Mechanism of in vitro release kinetics of flurbiprofen loaded ethylcellulose micropellets. Acta Pol Pharm, 59:193–198.
  • Murai K, Akazome G, Tani S, Oka Y. (1971). Microcapsular acid anhydrides. JP 48032816 A2.
  • Nelson LD. (1974). Weather modification using microencapsulated material. US 399009.
  • Nimmannit U, Suwanpatra N. (1996). Microencapsulation of drugs by the coacervation technique using ethylcellulose and acrylate-methacrylate copolymer as wall materials. J Microencapsul, 13:643–649.
  • Sakr FM. (1991). Studies on microencapsulated granules: Effect of drug-binder solubilities and added diluents on core properties and microencapsulation characteristics. J Drug Res, 20:303–313.
  • Suryakusuma H, Jun HW. (1984). Encapsulated hydrophilic polymer beads containing indomethacin as controlled release drug delivery systems. J Pharm Pharmacol, 36:497–501.
  • Salib NN. (1973). Microencapsulation and flocculation techniques in pharmaceutical formulation. III. Quantitative determination of the effect of coating/core ratio on drug release from phenobarbitone microcapsules and floccules. Pharm Ind, 35:217–219.
  • Suryakusuma H, Jun HW. (1984). Formation of encapsulated hydrophilic polymer beads by combined techniques of bead polymerization and phase separation. J Pharm Pharmacol, 36:493–496.
  • Oh DM, Lee MH. (1982). Characteristics of ethyl cellulose microcapsules of sulfisoxazole. Arch Pharm Res, 5:61–70.
  • Salib NN, El-Gholmy ZA, Hagar HHS. (1989). Controlled release indomethacin microcapsules. Part II: Utilizing the hydrophobic polymer ethyl cellulose. Alex J Pharm Sci, 3:183–186.
  • Öner L, Yalabik-Kas HS, Hincal AA. (1983). Microencapsulation and in vitro dissolution kinetics of dihydralazine sulfate. Conference proceedings: Expo.—Congr. Int. Technol. Pharm., 3rd, Assoc. Pharm. Galenique Ind.
  • Szretter D, Zakrzewski Z. (1984). Preparation of thiamin nitrate microcapsules. Acta Pol Pharm, 41:241–247.
  • Öner L, Yalabik-Kas S, Cave G, Hincal AA. (1984). Microencapsulation and in vitro dissolution kinetics of dihydralazine sulfate. Labo-Pharma—Problemes et Techniques, 346:690–693.
  • Szretter D, Zakrzewski Z. (1987). Microencapsulation of nicotinamide by solidification or coacervation of the coating materials. Acta Pol Pharm, 44:555–559.
  • Oner L, Kas HS, Hincal AA. (1988). Studies on zinc sulphate microcapsules (1): Microencapsulation and in vitro dissolution kinetics. J Microencapsul, 5:219–223.
  • Pandell NW, Temin SC. (1972). Application of reactants and/or catalysts to textile fabrics in microencapsulated form. US 3632296 A.
  • Anon. (1981). Preparation of microcapsules. JP 58049433 A2.
  • Anon. (1982). Production of microcapsules which do not aggregate. JP 63007091 B4.
  • Sevgi F, Ozyazici M, Güneri T. (1994). Sustained-release dosage form of phenylpropanolamine hydrochloride. Part I: Microencapsulation and in vitro release kinetics. J Microencapsul, 11:327–334.
  • Tateno A, Shiba M, Kondo T. (1978). Electrophoretic behavior of ethyl cellulose and polystyrene microcapsules containing aqueous solutions of polyelectrolytes. Conference proceedings: Emulsions, Latices, Dispersions, Dekker.
  • Shear J, Kershman A. (2000). Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals using lipids and surfactants. WO 2001049272 A3.
  • Shekerdzhiiski R, Pham TC, Titeva S. (1988). Microencapsulation of ferrous fumarate. Farmatsiya (Sofia, Bulgaria), 38:16–25.
  • Titeva S, Mantelos G, Shekerdzhiiski R, Minkov E, MitikovKr. (1986). Effect of coating agents on microencapsulation of ascorbic acid. Farmatsiya (Sofia, Bulgaria), 36:35–43.
  • Shekhare C, Gupta BK. (1989). Preparation and in-vitro evaluation of ethyl cellulose micropellets. Eastern Pharmacist, 32:135–138.
  • Tomova V, Shopova S, Velikova E, Stanoeva L. (1988). Microencapsulation of active substances. I. Characterization of polymer films for coating. Farmatsiya (Sofia, Bulgaria), 38:37–42.
  • Anon. (1980). Production of aspirin microcapsules. JP 56049315 A2.
  • Rao KR, Senapati P, Das MK. (2005). Formulation and in vitro evaluation of ethyl cellulose microspheres containing zidovudine. J Microencapsul, 22:863–876.
  • Shopova S, Tomova V. (1982). Study of the microencapsulation of ascorbic acid. Farmatsiya (Sofia, Bulgaria), 32:32–37.
  • Yalabik-Kas HS. (1983). Microencapsulation and in vitro dissolution of oxazepam from ethyl cellulose microcapsules. Drug Dev Ind Pharm, 9:1047–1060.
  • Unno K, Goto A, Murota H, Echigo M, Kato T, Nemoto R, Mori H. (1981). Study on microencapsulation of anticancer drugs. 1. Microencapsulation of anticancer drugs and their dissolution rate. Byoin Yakugaku, 6:244–250.
  • Vishwanath K, Sharma SN. (1978). Formulation of diphenhydramine into sustained action dosage form. Part I. Indian J Pharm Sci, 40:99–100.
  • Vitek R. (1978). Clean grip, pressure-sensitive adhesive tape or film. DE 2820051 A1.
  • Yoon MA, Yong JI. (1987). Pharmaceutical studies on microencapsulated propranolol hydrochloride. Yakche Hakhoechi, 17:67–73.
  • Yoshida H, Uesugi T, Noro S. (1980). [The effect of physical condition in first emulsification for yield of microcapsules (author’s transl)]. Yakugaku Zasshi, 100:1203–1208.
  • Zhang RC. (2002). Preparation of microcapsules by drying-in-liquid with a [(OI/WI)/OII]/WII multi-emulsion. Chem Res Chin Univ, 18:438–440.
  • Zhang Y, Chen L, Li B, Hua Z, Wu Y, Liu Z, Lu W. (2004). Effects of processing parameters on ethylcellulose microencapsulation using supercritical CO2 antisolvent precipitation. Shipin Kexue, 25:96–99.
  • Weiss G, Yamaguchi H, Ibuki R, Yasumura M, Ohnishi N. (1998). Microencapsulation of the renin inhibitor FK906 by phase separation of ethylcellulose in cyclohexane. J Microencapsul, 15:335–346.
  • Zhelyazkova Zh, Petrova G. (1984). Effect of some technological factors on the properties of microcapsules of iron (II) sulfate. Farmatsiya (Sofia, Bulgaria), 34:35–39.
  • Zhelyazkova Zh Dilov, P, Chakarov R, Isaev I. (1985). Drug forms with microencapsulated iron (II) sulfate. Problemi na Farmatsiyata, 13:49–55.
  • Williams D, Meier PM, Gron P, Hitchcock CJ, Mullins TJ, Bowen WH. (1982). Cariostatic microcapsules for aerosol delivery. J Pedod, 6:218–228.
  • Witz I. (1982). Microcapsules for pressure sensitive recording materials. GB 2017624 B.
  • Zou L, Zhang X, Zhang J, Chu L. (1991). Preparation of ampicillin sodium-ethylcellulose and sulfadimidine-gelatin microcapsules and the sustained release of the microcapsules. Shandong Yike Daxue Xuebao, 29:162–164.
  • METHOCEL™ website. (2007). www.methocel.com.
  • METHOCEL™ website. (1962). Printing process. DE 1128872.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.